Literature DB >> 25312013

Evidence for peripheral immune activation in amyotrophic lateral sclerosis.

Xueping Chen1, Weihua Feng2, Rui Huang1, Xiaoyan Guo1, Yongping Chen1, Zhenzhen Zheng1, Huifang Shang3.   

Abstract

There is evidence of the activity of immune system in the spinal cords of patients with amyotrophic lateral sclerosis (ALS), however; few studies to date have explored the status of peripheral immune response in ALS patients. Blood samples from 284 ALS patients and 217 aged-match controls were evaluated, and parameters of T cell subset, humoral immunity, and complement system activation were observed. CD4+ T lymphocytes and circulating immune complexes (CICs) were significantly decreased, and component C3 was significantly increased in ALS patients compared with normal controls. Patients with severe or moderate impairment had a higher CD4+ T cell percentage and a lower IgG levels when compared to those with mild impairment. There was an inverse correlation between CD4 T cell percentage and both revised ALS Functional Rating Scale (ALSFRS-R) score and disease duration, but the correlation was positive between IgG level and both ALSFRS-R score and disease duration among ALS patients. These correlations were gender-specific. This investigation demonstrated the existence of peripheral immune abnormalities in ALS patients.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; CD4+ T lymphocytes; Disease duration; IgG; Peripheral immune activation; Revised ALS Functional Rating Scale (ALSFRS-R)

Mesh:

Substances:

Year:  2014        PMID: 25312013     DOI: 10.1016/j.jns.2014.09.025

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  Impact of peripheral immune status on central molecular responses to facial nerve axotomy.

Authors:  D O Setter; E M Runge; N D Schartz; F M Kennedy; B L Brown; K P McMillan; W M Miller; K M Shah; M M Haulcomb; V M Sanders; K J Jones
Journal:  Brain Behav Immun       Date:  2017-10-10       Impact factor: 7.217

2.  Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.

Authors:  Rebecca K Sheean; Fiona C McKay; Erika Cretney; Christopher R Bye; Nirma D Perera; Doris Tomas; Richard A Weston; Karlene J Scheller; Elvan Djouma; Parvathi Menon; Stephen D Schibeci; Najwa Marmash; Justin J Yerbury; Stephen L Nutt; David R Booth; Graeme J Stewart; Mathew C Kiernan; Steve Vucic; Bradley J Turner
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

3.  [Proteomic analysis of the cerebrospinal fluid from patients with amyotrophic lateral sclerosis based on tandem mass spectrometry technique].

Authors:  Dandan Su; Yong Zhang; Fangfang Bi; Bo Xiao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

4.  Evidence for Peripheral Immune Activation in Parkinson's Disease.

Authors:  Xueping Chen; Weihua Feng; Ruwei Ou; Jiao Liu; Jing Yang; Jiajia Fu; Bei Cao; Yongping Chen; Qianqian Wei; Huifang Shang
Journal:  Front Aging Neurosci       Date:  2021-04-30       Impact factor: 5.750

5.  CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves.

Authors:  Anna Martínez-Muriana; Renzo Mancuso; Isaac Francos-Quijorna; Adrian Olmos-Alonso; Rosario Osta; V Hugh Perry; Xavier Navarro; Diego Gomez-Nicola; Ruben López-Vales
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

6.  Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis.

Authors:  YongPing Chen; QianQian Wei; XuePing Chen; ChunYu Li; Bei Cao; RuWei Ou; Shinji Hadano; Hui-Fang Shang
Journal:  Front Mol Neurosci       Date:  2016-08-17       Impact factor: 5.639

7.  New insights into SMA pathogenesis: immune dysfunction and neuroinflammation.

Authors:  Marc-Olivier Deguise; Rashmi Kothary
Journal:  Ann Clin Transl Neurol       Date:  2017-05-18       Impact factor: 4.511

8.  Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis.

Authors:  Mengli Wang; Zhen Liu; Juan Du; Yanchun Yuan; Bin Jiao; Xuewei Zhang; Xuan Hou; Lu Shen; Jifeng Guo; Hong Jiang; Kun Xia; Jianguang Tang; Ruxu Zhang; Beisha Tang; Junling Wang
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

9.  Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis.

Authors:  Mengmeng Jin; Rene Günther; Katja Akgün; Andreas Hermann; Tjalf Ziemssen
Journal:  Sci Rep       Date:  2020-04-03       Impact factor: 4.379

10.  Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant).

Authors:  Steve Vucic; Julie Ryder; Linda Mekhael; Henderson Rd; Susan Mathers; Merilee Needham; Schultz Dw; Kiernan Mc
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.